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ABSTRACT
A current method in addressing subfertility in stallions include manipulating the semen extender
media by supplementing antioxidants and energy sources. Two experiments (EXP 1/EXP 2)
were conducted to assess the effects of pyruvate and Oxyrase® suspended in commercial diluents
for preservation of stallion spermatozoa. Assessment of total (TM) and progressive motility
(PM), velocity and direction of movement (VAP, VSL, VCL, and elongation) were recorded by
CASA. In EXP 1, 3 different ejaculates were collected from each of 4 stallions. Aliquots of each
ejaculate were suspended into 4 treatments of INRA96 with or without Oxyrase® supplemented
at 2.4 U/ml and centrifuged or not centrifuged. Aliquots of each treatment were split for analysis
by CASA after 2 hours, 24 hours, and 48 hours of storage. In EXP 2, 3 different ejaculates were
collected from each of 3 stallions. Two of five aliquots were suspended in skim-milk glucose
(SKMG) or SKMG modified by the addition of sucrose (SKMG+S). The remaining diluents
were formulated with 2.4 instead of 4.9 g of glucose per 100ml and with increasing amounts of
pyruvate. Method of storage and analysis was consistent through EXP 2. In EXP 1 the addition
of Oxyrase® did not improve (P<.05) post storage motility of stallion spermatozoa. At all times
in EXP 2 the diluents SKMG+S and SKMG demonstrated numerically higher TM and PM than
extenders with substituted pyruvate. In conclusion, addition of Oxyrase® in INRA96 and
substitution of pyruvate in diluents with formulas commonly used demonstrated no beneficial
effects to stallion spermatozoa survival.
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INTRODUCTION

Justification
Cold storage of spermatozoa acts on the metabolic process by slowing and decreasing
depletion of the energy stores. The effect cold storage has on each stallion is variable. When
researching the optimal extender for stallions, one must acknowledge that one extender may
work better than another for an individual stallion. Therefore, no single protocol has been
identified as the most efficient among the population of stallions. Developing an extender to
prolong and improve the ability of stallion spermatozoa to handle cold storage stress improves
several factors [1]:
1. Increase breeder access to stallion’s superior genetics.
2. Increase overall market area for stallion semen.
3. Increase longevity of spermatozoa allowing for an increase in flexibility, which will
allow a way to circumvent problems with delivery schedules of shipped
inseminations.
4. Decrease the number of shipments required per pregnancy.
5. Allow for more insemination doses per ejaculate.
A current method in addressing subfertility in stallions include, manipulating the semen
extender media by supplementing antioxidants and energy sources. The goal of supplementing
these components is to increase post-storage survivability for cooled and cryopreserved
spermatozoa [1 - 11]. Energy sources including skim milk, glucose, and egg yolk compose the
majority of popular extenders. However, semen extender media are not limited to those specific
substrates. Other potential energy source include pyruvate, the product of glycolysis.
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Pyruvate acts as an intermediate compound in the metabolism of simple sugars (mainly
glucose), fatty acids, and amino acids. Compared to glycolytic substrates (glucose), pyruvate is a
more direct substrate in the mitochondrial pathway of oxidative phosphorylation [2]. Stallions
prefer the oxidative phosphorylation pathway to glycolysis as the main energy provider for
spermatozoa function [12]. An inadequacy of an energy substrate is detrimental and leads to
mitochondrial dysfunction/decreased motility of spermatozoa [2]. For this reason, mitochondrial
energy inputs, like pyruvate, are crucial to energy production.
The aforementioned inadequacy of an energy substrate causing mitochondrial
dysfunction not only decreases motility but also increases reactive oxygen species (ROS)
production [2]. Oxidative stress, brought on by the upregulation of ROS, and the byproducts it
produces are thought to be a major factor in spermatozoa cell death [3]. To counter this effect,
antioxidants, which reduce free radicals produce from oxidative stress, can be supplemented into
the media of cooled or cryopreserved spermatozoa. Several compounds have been studied as
possible antioxidant additives to semen extenders, including, glutathione peroxidase, catalase,
tocopherol, pyruvate, and superoxide dismutase [4 - 6]. Oxyrase®, has been recently used in
cryopreservation protocols as a supplemental antioxidant to aid in protection from freeze-thaw
damaging effects in stallions, monkeys, and mice [3,13,14]. In recent studies, contradicting
evidence regarding Oxyrase® has been demonstrated to improve or not effect motility of stallion
spermatozoa [3,7]. Variability within stallions and ejaculates from each study could be a major
contributing factor for the inconsistent results. Cryopreservation effects were found with
Oxyrase®. However, there is little research on effects of cooled stallion spermatozoa
supplemented with Oxyrase®. The addition of Oxyrase® in extended treatments for cold storage
should be further researched.
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Determination of the effectiveness of pyruvate and Oxyrase® capability to prolong and
improve the ability of the spermatozoa when under cold storage was analyzed at increasing time
increments (2, 24 and 48 h). Motility and velocity were recorded in order to analyze the effect on
the spermatozoa.

Problem Statement
Deleterious effects from cold storage on stallion spermatozoa can decrease the motility
and velocity, thus, incapacitating the paternal DNA transporters and decreasing the chance of
fertilization. Suspension of spermatozoa in an extender with adequate supply of energy and/or
protective compounds will allow for prolonged survival in cold storage.

Objective
Objectives of the two experiments reported in this thesis were to determine the effects of
supplemented Oxyrase® and pyruvate in commercially available extenders on motility and
velocity of cold stored stallion spermatozoa.

Null Hypotheses
1. EC-Oxyrase® will not increase post storage motility and velocity of stallion
spermatozoa
2. Substituted pyruvate in a skim milk glucose extender will not improve post storage
motility and velocity of stallion spermatozoa when compared to commercially
available extenders.
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LITERATURE REVIEW

Spermatozoa Structure
Anatomically, the structure of the spermatozoa consists of four major parts: the head,
middle piece (midpiece), principle piece, and end piece (Figure 1). The head, midpiece, and
entire sperm cell is enveloped in a phospholipid bilayer membrane. The previous components of
the spermatozoa structure will be the focus of this literature review.

Figure 1. Anatomical structure of a spermatozoon [15].

Phospholipids are amphipathic and have a polar head that contain a phosphate and
glycerol. Nonpolar, hydrophobic fatty acids make up the tail of the phospholipid [16]. Alignment
of the phospholipids from both sides of the bilayer serve as a barrier to deter water and other
polar or charged substances from crossing the membrane. Embedded within the membrane are
proteins, carbohydrates, and cholesterol [16].
Proteins make up approximately 50% of the total membrane molecular weight. Placement
of the protein influences the role that it serves to the spermatozoa. Integral proteins act as ion
channels, pores, receptors, and signal transduction components. Proteins receptors for various
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hormones are located on the outer layer and glycocalyx (densely packed oligosaccharides
attached to cell-surface proteins and lipids) of spermatozoa [17]. Proteins associated on the
outside of the spermatozoa include lipid-linked proteins, which contain covalently attached lipids
that anchor itself to the lipid membrane. In addition, peripheral membrane proteins lie on the
exterior of the membrane and are not bound to any lipids but most likely bound to integral
proteins [17]. Carbohydrates are strictly present on the outer portion of the plasma membrane,
attaching to proteins or lipids forming glycoproteins or glycolipids [16].
Cholesterol, a four ringed carbon lipid, is located within the cell membrane core and aids
in minimizing the change in fluidity from temperature changes. In low temperatures, cholesterol
helps maintain a high fluidity by preventing phospholipids from packing tightly together.
Stallion spermatozoa have a lower cholesterol to phospholipid molar ratio, 0.36, when compared
to bulls, 0.45. This likely contributes to the higher susceptibility of cold shock in stallion
spermatozoa [18 – 20]. Species with a higher cholesterol to phospholipid ratio, similar to bulls,
exhibit a greater tolerance to temperature changes due to the stability of the membrane at low
temperatures.
Located between the plasma membrane and the nucleus, lies the acrosomal matrix.
Within the matrix, the inner acrosome is in close contact with the nuclear envelope surrounding
the nucleus, while the outer acrosome lies beneath the plasma membrane. Enzymes within the
acrosome include proacrosin, acrosin, hyaluronidase, and lipases that are important for
penetration of the oocyte after the acrosome reaction [21]. During the acrosome reaction, hybrid
vesicles and pores are created when the outer portion of the acrosome attaches with the overlying
plasma membrane, therefore, allowing the release of the acrosomal contents and paternal genetic
material from the fertilizing sperm [22]. Chromatin, containing the paternal genetic material
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DNA, is densely packed within the nucleus and is surrounded by the nuclear envelope. Posterior
to the chromatin is the implantation fossa, the point of attachment for the flagellum [23].
Attaching to the implantation fossa, the capitulum, is a specialized structure within the
connecting piece, forms the cranial border of the flagellum. Proteins rich in disulfide bonds make
up the cranial border. The connecting piece is responsible for attaching the midpiece to the head
of the spermatozoon. Within the midpiece is the mitochondrial matrix. In spermiogenesis, the
final stage of spermatogenesis, mitochondria assume a final spiral alignment in the matrix.
Alignment of mitochondria in this position are known as gyri (Figure 2) [24].

Figure 2. Cross sectional view of the middle piece (midpiece) in stallion spermatozoa [23].

Each gyri contains approximately 40-50 mitochondria. Order and symmetry of gyri play
a significant role in mitochondria as they may express a functional effect. Disruptions of the
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order and symmetry of the gyri have been linked reducing fertility rate in stallions [24].
Fertilization relies heavily on the function of mitochondria to produce and store ATP for
spermatozoal motility and survival.

Spermatozoa Metabolism
Spermatozoa function as carriers of paternal DNA, and triggers/activates the female
oocyte upon fertilization, a process that is highly energy dependent. Spermatozoa are not solely
responsible for movement to the oviduct, uterine contractions also aid in the transport to site of
fertilization. For successful fertilization to occur, spermatozoa require the production of ATP for
capacitation, hyperactivation, and the acrosomal reaction. When undergoing capacitation,
structural and functional changes occur which include membrane modifications, modulation of
enzymes, and protein phosphorylation. Hyperactivation accompanies capacitation and is
indicated by an increase in flagellar bend amplitude. Hyperactivation is critical for movement
through the ovidcutal mucus and to penetrate the zona pellucida of the oocyte after the acrosomal
reaction.
The site of sperm deposition, the uterus, is distant from the site of fertilization, the
oviduct. Therefore, sufficient production of ATP is essential for motility in order for
spermatozoa to reach the oviduct for fertilization [21]. Two major metabolic pathways that
provide ATP for spermatozoa are glycolysis and oxidative phosphorylation (OXPHOS).
Glycolysis. Glucose is broken down in a two-phase process known as glycolysis. Phase
one of glycolysis consumes two molecules of ATP in order to initiate glucose catabolism. During
phase one, the glucose is phosphorylated and split to yield two molecules of glyceraldehyde-3phosphate. During phase two, the two molecules of glyceraldehyde-3-phosphate are converted
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into pyruvate, subsequently, generating four ATP from the process. Thus, glycolysis has a
consumption of two ATP and a production of four ATP for a net total of two ATP produced per
glucose [17].
Glycolytic enzymes and glucose transporters (GLUTs) allow passage through the lipid
bilayer and determine location of glycolysis. Glycolytic activity, transporters of glucose and
enzymes are entirely localized in the fibrous sheath of the flagellum and the acrosome [25].
Distribution of GLUTs suggest that glycolytic processes mainly produce energy for the changes
induced on the cell membrane during capacitation and the acrosomal reaction. Bucci et al., [26]
described the dispersal of GLUTs as evidence of the function status of the sperm in dogs; this
has yet to be seen in equine [26].
Production of ATP between the two metabolic pathways differs. Oxidative
phosphorylation produces an approximate ATP total of 26 – 28 and is more ATP productive than
glycolysis. Glycolysis produces an approximate net total of two ATP and two NADH. Some
species (e.g. humans and mice) rely almost entirely on glycolysis for ATP production [25], but
the preferred metabolic pathway is highly species specific [27]. Both pathways run in
concurrence with one another. When supplementing energy is considered, then the knowledge of
the pathway desired by a specific species is required to optimize a more direct energy
production.
Oxidative Phosphorylation. Recent studies indicated that stallion spermatozoa rely
almost entirely on OXPHOS for energy supply [12,28]. In order to ascertain which pathway is
primarily relied on, a comparison between stallions and a known glycolysis utilizer (humans)
was conducted. Diphenyleneiodonium (DPI; a flavoprotein inhibitor of the mitochondrial
electron transport chain) was selected as a mitochondrial (OXPHOS) inhibitor on motility and

8

velocity. Within human spermatozoa, no effect was observed when DPI was added as human
spermatozoa does not rely on OXPHOS. Therefore, these results were expected. Stallions,
however, were detrimentally effected by the DPI indicating a heavy reliance on OXPHOS for
energy [12].
Stallions preferred metabolic pathway, OXPHOS, takes place within the mitochondrial
matrix in the intermembrane spaces. At this location, energy is produced through protein
complexes. Oxidative phosphorylation utilizes more diverse substrates when compared to
glycolysis. Unlike glycolysis, there is not a single main substrate (e.g. glucose) metabolized to
further the process of ATP production. Substrates utilized, generally stem from derivatives from
the catabolism of carbohydrates, lipids, and proteins.
Utilization of OXPHOS over glycolysis for the main production of ATP is appropriate
due to stallion spermatozoa velocity parameters being 60% faster than human parameters;
requiring a longer lasting energy producing system for motility. Subsequently, high-energy
demands of the stallion spermatozoa lead to a lower concentration of ATP when compared to
human spermatozoa [12]. Gibb et al. [12] hypothesized, higher levels of OXPHOS in more
fertile stallions, increased mitochondrial activity, leading to an increase in the byproduct of
oxidative stress.

Reactive Oxygen Species
Reactive oxygen species (ROS), byproducts of oxidative stress, effect fertilization and
embryonic development. Therefore, ROS can cause developmental abnormalities in offspring
and pregnancy loss. The latter likely result from oxidative damage done to DNA within the
spermatozoa cells [29]. Vulnerability of spermatozoa to oxidative attack is intensified by the fact
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that these cells actively generate reactive oxygen species. But, production of ROS is necessary
for capacitation of spermatozoa prior to fertilization. However, when spermatozoa are stressed,
the role of ROS turns to an intrinsic apoptotic pathway [30].
Reactive oxygen species can be detrimental to spermatozoa [31]. Spermatozoa
membranes consist of polyunsaturated fatty acids (PUFAs), particularly docosahexaenoic acid,
which are highly vulnerable to free radical attack [30]. Free radicals attack the PUFAs generating
a variety of lipid metabolites, including lipid radicals (Figure 3a.) and aldehydes like 4hydroxynonenal (4HNE) [32,33]. Lipid radicals then combine with oxygen, an electron acceptor,
producing a peroxyl radical (Figure 3b.). Destabilization of the lipid membrane occurs by the
extraction of hydrogen atoms to stabilize the radicals own structure. To achieve stability, the
peroxyl radical eradicates a hydrogen from a nearby PUFA to form a lipid hydroperoxide. The
eradication process perpetuates the production of lipid peroxyl radicals continuing the progress
of lipid peroxidation. (Figure 3c.) [30].
Lipid aldehydes (4HNE) produced from peroxidation attach to mitochondrial proteins.
Aldehydes can bind to mitochondrial proteins, like succinic acid dehydrogenase, triggering the
electron leakage forming additional ROS, continuing peroxidation [30]. As the cycle continues,
spermatozoa enter an apoptotic pathway losing membrane potential and eventually resulting in
damage to DNA strands [34]. Spermatozoa DNA damage is mostly due to hydroperoxide, which
is the only apoptotic product that can pass from the midpiece to the head. Continuation of
oxidative stress will increase the lipid peroxidation cycle and lead to cell death [35].
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(a)

(b)

(c)

Figure 3. Lipid peroxidation in the mammalian cell [30].

Spermatozoa also lack intracellular antioxidant protection as provided by catalase and
glutathione peroxidase, common metabolizing enzymes of ROS. In stallions, catalase is abundant
in the seminal plasma (SP) but limited intracellularly due to restricted volume of space within the
spermatozoa membrane [30,36]. Catalase, along with glutathione peroxidase, is used for the
removal of hydroperoxide within the spermatozoa [31]. If catalase and/or the glutathione
reductase system is inefficient, hydroperoxide will generate more lipid radicals via the Fenton
reaction (e.g., iron or copper reaction with hyrdoperoxide). However, this can be eliminated by
nonenzymatic antioxidants like ascorbic acid and α-tocopherol within the cell wall [37].
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Consequently, removal of the SP, also removes several enzymatic and nonenzymatic
antioxidants, which subsequently, removes the beneficial actions of antioxidants. In contrast, the
removal of SP can be beneficial to sperm motility. Dawson et al. [38], suggested that decreasing
the amount of time spermatozoa remained in an undiluted state without SP, increased the post
storage recovery of progressive motility and acrosome-intact stallion spermatozoa [38]. Removal
of SP is utilized to concentrate the number of spermatozoa and remove detrimental components
[39]. Cryopreservation and cooling protocols of semen, generally, consist of centrifugation, a
method used to remove SP. Consequently, natural antioxidants in the SP are removed when
semen is centrifuged, thus allowing for an increased amount of ROS produced [11].
Hydroxyl radicals have been shown to be detrimental to spermatozoa DNA [40]. Even
with the presence of SP (which includes catalase), hydroxyl radicals were deleterious to DNA
integrity. Fragmentation of DNA without SP occurred at 92.7 ± 3.2%, compared to
fragmentation with SP at 13.0 ± 6.1% [40]. Therefore, demonstrating presence of antioxidants
aid in reducing the damage from radicals. Antioxidant protection is crucial to breaking up
hydroperoxide via catalase and glutathione peroxidase [41], subsequently inhibiting formation of
hydroxyl radicals [40]. Addition of antioxidants has been suggested when SP is not present as a
method to prevent negative reactions from occurring [41].

Oxyrase®
Oxygen has a primary role in formation of ROS; consequently, this may lead to an effect
on amount of O2 radicals within the spermatozoa. The continuing revolution of lipid peroxidation
in spermatozoa is a linear function of partial pressure of oxygen (O2) in the medium [42]. In
order to attain low O2 tension, integration of commercially available antioxidants, like Oxyrase®,
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may be beneficial [14]. Pyruvate acts as an antioxidant and aid in deterring induced
hydroperoxide damage by peroxidation of lipids in ram and bull spermatozoa [5,10]. However,
stallion spermatozoa (frozen-thawed and nonfrozen) are less susceptible to peroxidation than bull
spermatozoa [43] and contain a higher amount of catalase [8]. Therefore, pyruvate in stallion
spermatozoa act as a readily energy substrate and not as an antioxidant to stallion spermatozoa
[1]. Based on the prior research, the antioxidant Oxyrase® could be beneficial when
supplemented to stallion spermatozoa.
Oxyrase® is obtained from the cytoplasmic membrane of the microorganism Escherichia
coli (EC), and contains an excerpt of bacterial electron transport systems [44]. The product ECOxyrase® (product number: EC-0005, Oxyrase® Inc.), contains 100mM DL of lactate. With the
presence of lactate, a suitable hydrogen donor, Oxyrase® can reduce oxygen in solutions [44].
Oxyrase® is suggested to be “nature’s antioxidant,” due to its ability to reduce free radicals in a
solution creating an anaerobic environment (Oxyrase® Inc). Stallion spermatozoa survivability
has been hypothesized to improve when cooling or freezing procedures include Oxyrase®,
creating a more anaerobic environment [2,7]. Oxyrase® has not only been used in
cryopreservation of stallion spermatozoa but also supplemented in monkey and mouse
cryopreservation protocols with a significant (P<0.05) beneficial effect [13,14].
Darr et al. [2] analyzed the effects of reducing oxygen concentration using Oxyrase®, the
oxygen scavenger, on motility of frozen-thawed stallion spermatozoa. Six stallions with low
progressive motility measurements (<50% PM) were selected for treatments to increase
sensitivity of Oxyrase®. Results are listed in Figure 4 and demonstrate the effectiveness of
Oxyrase® compared to a control group without Oxyrase®. Treatment of 2.4 U/ml Oxyrase®
supplemented prior to cryopreservation significantly increased motility over 24 h of
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measurements (P < 0.05) when compared to control. Other treatments (0.6, 1.2 and 5 U/ml)
tended to have a higher motility but were not significant. However, results from the previous
study indicated a post thaw (T0) progressive motility at approximately 30%, which is considered
fair semen quality and results in an approximate pregnancy rate of 33% [45]. Oxyrase®
demonstrated improvement in stallions with <50% progressive motility but still demonstrated a
lower fertility.

Figure 4. Oxyrase® concentration effect on progressive motility over a 24 hour period post thaw
[2].

14

Contrary to the previously study, London et al. [7] demonstrated Oxyrase® did not have
any significant effect improving motility parameters or display any protective effects on the cell
membrane viability (P > 0.05) [7]. Stallions selected were not of lower progressive motility as
used in the Darr et al. [2] study. Stallions displaying a higher rate of fertility are hypothesized to
have higher levels of OXPHOS, with oxidative stress as a by-product of this increased level of
metabolism [12]. Level of fertility, extender used and variability within stallions selected could
explain the contradicting data from both London et al. [7] and Darr et al. [2].
Utilization of Oxyrase® as a supplement for increasing motility and membrane protector
should be further studied due to the high variability in current research. Treatment of Oxyrase®
has demonstrated effects with cryopreservation. However, there is little research on effects of
cooled stallion spermatozoa supplemented with Oxyrase®. Manipulating spermatozoa
metabolism with the extender is a technique to increase preservation and function of
spermatozoa prior to insemination [3]. Oxidative stress and production of ROS are detrimental to
spermatozoa health, thus an extender should be used. Furthermore, the origin of the issue may
stem from an inadequate amount of metabolizable substrate, which can lead to an increase in
production of ROS and more oxidative stress on the spermatozoa [3].

Pyruvate
Pyruvate is a 2-oxo monocarboxylic acid anion that stems from deprotonation of the
carboxylic group of pyruvic acid. Deriving from a propionate, pyruvate’s IUPAC ID is 2oxopropanoic acid with the chemical formula of C3H3O3. This compound is a cornerstone
molecule crucial to a variety of anabolic and catabolic pathways including: oxidative
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metabolism, gluconeogenesis (re-synthesis of glucose), lipogenesis (synthesis of new lipids),
cholesterol synthesis, and maintenance/support of citric acid cycle [46].
Major sources of pyruvate are phosphoenolpyruvate via pyruvate kinase (PK), lactate via
lactate dehydrogenase (LDH) and alanine via alanine aminotransferase (ALT) [47]. The
predominant production of pyruvate comes from the anaerobic breakdown of glucose via
glycolysis into two pyruvate molecules. Pyruvate kinase, is the enzyme that takes
phosphoenolpyruvate, the final molecule in glycolysis, and breaks it down into the two
subsequent molecules of pyruvate (Figure 5a) [46]. Oxidation of lactate is another significant
source of pyruvate. Lactate dehydrogenase, the enzymes responsible for the oxidation of
pyruvate, produces a significant portion of pyruvate for metabolism (Figure 5b) [46]. One last
important source of pyruvate is catabolism of the three-carbon amino acid, alanine, via ALT
(Figure 5c) [47]. Within the mitochondrial matrix, ALT is also found to convert alanine, which
was transported into the matrix, into pyruvate (Figure 5d) [48]. Other amino acid sources of
pyruvate within the cytosol include serine, threonine, glycine, cysteine, and tryptophan [46].
Overall, these enzymes and other molecules contribute to the production of pyruvate within most
cells, including spermatozoa.
Pyruvate present in the cytosol is transported into the matrix via mitochondria pyruvate
carrier [49]. The mitochondria pyruvate carrier assists as a highly important linkage between the
cytosol and mitochondrial pyruvate metabolism [47]. Once pyruvate reaches the matrix, one of
two enzymes, pyruvate dehydrogenase complex (PDH) or pyruvate carboxylase (PC) [46], can
metabolize it. The majority of the pyruvate is oxidized via PDH to form acetyl-CoA and NADH
from NAD+. Acetyl-CoA is primarily converted to 2CO2 and energy created during the process
produces NADH and FADH2, which are crucial to the proton gradient required for OXPHOS
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Figure 5. Sources and enzymes involved with the production of pyruvate [47].

and ATP production [46]. Pyruvate carboxylase, the second enzymes acting on pyruvate,
generates oxaloacetate and serves as an acceptor for acetyl-CoA. The PC reaction also acts to
replenish citric acid cycle intermediates [50].
Research has suggested pyruvate can have possible antioxidant effects on rams, bulls, and
stallions [5,6,10,51]. In order to ascertain antioxidant actions of pyruvate in spermatozoa,
hydrogen peroxide (H2O2) has been used to induce lipid peroxide damage that could potentially
be offset by different antioxidants, including pyruvate. In a study on frozen- thaw bull
spermatozoa challenged with H2O2, the addition of pyruvate or other antioxidants was able to
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offset the effects of induced lipid peroxidation from H2O2 [5]. However, studies within stallions
have demonstrated contradicting results on pyruvates action as an antioxidant. Bruemmer et al.
[51] indicated pyruvate to have antioxidant like effects when supplemented into a skim milk
diluent that was subjected to cold storage for 48 h. These results indicated a higher motility and
velocity from the addition of pyruvate when compared to a treatment without pyruvate [51].
In agreement with the previous research, Cavinder et al. [6] found inclusion of pyruvate
to be effective in improving motility in a skim milk extender, as well as, protecting against low
levels of 0.1, 0.3, and 0.6 mmol H2O2 for up to 72 hours of storage [6]. Furthermore, the previous
study had indicated that a level of at least 0.8 mmol of H2O2 was needed in order to cause
detrimental effects to spermatozoa. A study from Webb and Arns [1] found levels of 0.8 and 1.6
mmol H2O2 to a skim milk extender with the addition of pyruvate and lactate did not result in
consistent improvement in total motility. Results concluded pyruvate was unable to prevent the
damaging effects from H2O2, therefore indicating pyruvate serves predominantly as an energy
source and not an antioxidant within stallion spermatozoa [1]. Furthermore, an explanation for an
increase in the resistance from peroxidation in stallions, when compared to bulls, could be due to
a higher concentration of catalase within the seminal plasma as well as the spermatozoa [8].
Potter et al. [9] have recently researched inclusion of pyruvate in popular extenders.
Within that study, the extenders SKMG, INRA 96 (IMV Technologies, Maple Grove, MN), and
Revolution™ (Santa Cruz Biotechnology, Dallas, TX) extenders were utilized as subjects for
pyruvate supplementation. The extender SKMG and Revolution™ extenders tended to benefit
from the supplementation of pyruvate. However, a strong statistical significance was not
demonstrated within the two. The extender INRA 96 did not show a benefit (P>0.05) from the
supplemented pyruvate. Within the trial, INRA 96 proved to be the superior extender when

18

compared to SKMG and Revolution extenders. Although INRA 96 has shown to not benefit
from pyruvate supplementation, other popular extenders have benefitted from the addition of the
energy substrate [9]. As stated by Potter et al. [9], increasing the sample size could have added to
a more significant statistical difference within the extenders [9].
Research by Darr et al. [2] has indicated that pyruvate is a precursor/primary substrate
utilized in OXPHOS within spermatozoa mitochondria and could be a more efficient source of
energy when compared to glucose. Popular extenders, like SKMG, contain exclusively glucose
as the energy source. Levels of mitochondrial oxygen consumption (MITOX) and motility from
media containing solely glucose were incapable of maintaining the high levels produced from
pyruvate and lactate, which directly contribute to the citric acid cycle [3]. Mitochondrial health
has been linked to oxygen consumption and is positively correlated with sperm motility in
humans and stallions, indicating pyruvate can support a higher mitochondrial health [2,3,52,53].
Darr et al. [2] suggested, without OXPHOS substrates in the media, glucose could be the main
energy source due to breakdown into pyruvate via glycolysis. However, this could likely cause a
decrease in mitochondrial function due to lower concentration of pyruvate transport into
mitochondria [2]. Results from Darr et al. [2], indicate pyruvate as a more effect supplemental
substrate than the popular substrate, glucose. Manipulating the extender to increase more
effective energy substrates will allow for better preservation techniques and increased
spermatozoa health prior to insemination.
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METHODS

Research took place between mid-May and late-June at Missouri State University Darr
Agricultural Center in Springfield, MO. Housing, collection of stallions, and mares used within
the study were conducted at Pinegar arena. All procedures involving the care, management, and
use of equine in this project was approved by the Institutional Animal Care and Use Committee
of Missouri State University (IACUC #18-020.0-A). Funding of this project was by Missouri
State University Graduate College and Department of Animal Science funds.

Experiment 1
Collection and Processing. In order to stabilize extragonadal sperm reserves, stallions
were collected 4 times during the week prior to the beginning of the experiment. During the
experiment, three different ejaculates were collected each day on alternating days from four
different stallions. Stallions consisted of three American Quarter Horses (1 = Playboy; 3 = Blue;
4 = Dundee) and one miniature horse (2 = Roanie). Ejaculates were attained via a Missouri
artificial vagina (AV) lubricated with Priority Care® (First Priority, Inc., Elgin, IL), a nonspermicidal sterile lubricating jelly. Collection bottles were attached to the end of the AV and
warmed to 35°C prior to ejaculation into the bottle. Filters were placed in the collection bottle to
separate out gel portion of ejaculate. Stallions were teased by mares in estrus, if needed, and their
sheath cleaned prior to mounting of the phantom and collection. Once collected, 180 ul of the
ejaculate was pipetted into a 4 ml plastic cuvette containing formalin 10 solution. Cuvette was
then inverted and placed in a 590a Densimeter (Animal Reproduction Systems, Chino, CA) for
analysis of volume (ml) and concentration (million spermatozoa per ml).
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Treatments. Aliquots of semen were then divided into four 15 ml Falcon™ (Fisher
Scientific, Germany) test tubes. Two of the four tubes were centrifuged at 350 g-force for two to
four minutes or until consistency of a sperm pellet was attained. The base extender utilized
during experiment one consisted of the commercially available INRA 96 (IMV Technologies,
Maple Grove, MN). A factorial design was implemented in which two aliquots were centrifuged
and two had the INRA 96 supplemented with Oxyrase® at a level of 2.4 U/ml such that there
were four combinations which served as treatments for experiment 1 (Table 1.). The
supplemental amount of Oxyrase® was based off of the results from the study by Darr et al. [2].

Table 1. Centrifugation and Oxyrase® treatments for experiment one.
INRA96

Centrifugation
Oxyrase®

OxySP-

OxySP+

SP-

SP+

+

-

+

-

2.4 U/ml

2.4 U/ml

0

0

Extenders were premade, froze prior to collection, and thawed reaching a temperature
between 30°C to 35°C before suspension to ensure spermatozoa did not undergo cold shock.
Once thawed, treatment OxySP- and SP- were suspended into centrifuged semen, while the
remaining treatments (OxySP+ and SP+) were suspended into non-centrifuged semen. Aliquots
for each treatment were diluted at ratios (extender: semen) of 3:1 to 5:1 to insure concentrations
between 20 and 40 X 106 sperm per ml of diluted semen after centrifugation. Aliquots of each
treatment were then divide into three Fisherbrand® (Fisher Scientific, Germany) microcentrifuge
1.5 ml tubes. The three microcentrifuge tubes from each treatment were allocated into three
different Equine Express II™ (Exodus Breeders, York, PA) shipping containers for analysis after
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2, 24 and 48 h of storage. Once shipping containers had the allocated microcentrifuged tubes, a
Thermosafe® Polarpack® (Sonoco, Hartsville, SC) was placed inside the container for cooling
and storage in the lab at approximately 22°C. Cooling packs were replaced daily to maintain a
temperature of approximately 5°C. Each container was analyzed via computer assisted sperm
analysis (CASA; Hamilton Thorne Biociences, Beverly, MA).
CASA. Inversion of each treatment was performed by hand prior to analysis to insure
proper mixing. Samples were placed on a 4 chamber, 20 micron Leja® (IMV Technologies,
Netherlands) slide via a micropipette. Slide were placed on a slide warmer at 35°C for five
minutes to ensure cooling effects were not present and spermatozoa had full motility. Chambers
were analyzed individually on a microscope (Olympus, CX41, Japan). Within each chamber, 300
– 400 sperm cells were analyzed for parameters measured by CASA. The parameters measured
were total motility (TM), progressive motility (PM), average path velocity (VAP), straight-line
velocity (VSL), curvilinear velocity (VCL), and elongation (ELONG). Total motility is defined
as the population of cells that are moving at or above a predetermined minimum speed.
Progressive motility are cells moving with a predetermined speed and straightness. Average path
velocity is recorded as the average velocity of the smoothed cell path in microns/second.
Straight-line velocity is the average velocity measured in a straight line from the beginning to the
end of track. Curvilinear velocity is the average velocity measured over the actual point to point
track followed by the cell. Elongations is determined by the average value of the ratio of minor
and major axis of all sperm heads. The following instrument settings were used for CASA
analysis: frame rate, 60 Hz; number of frames acquired, 45; minimum contrast, 70; minimum
cell size, 5; motile VAP cutoff, 15.0 µ/s; motile VSL cutoff, 30.0 µ/s; progressive VAP, 30.0 µ/s;
progressive STR, 50.0%.
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Statistics. The general linear model procedure of ANOVA was used in Minitab 18
(Minitab Inc., State College, PA) for treatment analysis. Within ANOVA, the model consisted of
stallion and treatment split by time. Tukey’s pairwise comparisons analyzed stallion and
treatment effects.

Experiment 2
Collection and Processing. For experiment 2, three ejaculates were collected from each
of three stallions. Two stallions were American Quarter Horses (1 = Playboy; 3 = Blue) and one
stallion was a miniature horse (2 = Roanie). Ejaculates were collected and processed using the
same procedures as experiment 1, excluding the centrifugation procedure. All ejaculates
collected for experiment 2 were centrifuged at 350 g-force for two to four minutes or until
desired effect from centrifuge was attained. Once processed, aliquots of each ejaculate were
divided into five treatments allocated in 15 ml Falcon™ test tubes.
Treatments. Formulas for each treatment are listed in Table 2. Control treatments
consisted of the formulas similar to commercially used extenders, (SKMG=S) the Modified
Kenney Extender (Exodus Breeders, York, PA), containing 2.4 g of glucose and 4.0 g of sucrose,
and (SKMG) Next Generation® Kenney Extender, which contains 4.9 g of glucose. In order to
determine if some of the glucose could be replaced by pyruvate as an energy source, remaining
treatments were supplemented in the Kenney Extender (SKMG) and had a reduced glucose
amount of 50% from the original 4.9 g to 2.4 g within the extender. Treatments PYR2, PYR4,
and PYR8 were supplemented with increasing amounts of sodium pyruvate, 0.2 g, 0.4 g, and 0.8
g, respectively. Each extender was diluted into 92 ml/dl of BioWhittaker™ deionized water
(Cambrex Bio Science, Walkersville, MD). Antibiotics supplemented into each dilution included
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amikacin sulfate 1 g/dl and potassium penicillin 1 × 106 units/dl (KPenn; purchased from
reproductive resources). The optimal range for extender osmolality is between 300 and 400
mOsm/L [54]. Osmolality was adjusted by supplemented sodium chloride (NaCl) in treatments
PYR2 and PYR4 to equal that of the SKMG, PYR 8, and SKMG+S treatments (350 mOsm/L).
Each ejaculate made five separate treatments that followed the processing protocol, spermatozoa
parameter analysis, and statistical analysis listed in experiment. Treatment formulas with
differing amounts of pyruvate substituted in the SKMG extender were based off of results from a
study by Darr et al. [2].

Table 2. Formulas for semen extenders tested in experiment two.
Treatments
SKMG+S

SKMG

PYR2

PYR4

PYR8

Skim Milk Powder

5.0 g

5.0 g

5.0 g

5.0 g

5.0 g

Glucose

2.4 g

4.9 g

2.4 g

2.4 g

2.4 g

Sucrose

4.0 g

0

0

0

0

Na Pyruvate

0

0

0.2 g

0.4 g

0.8 g

Deionized Water

92 ml

92 ml

92 ml

92 ml

92 ml

*Antibiotics

+

+

+

+

+

**NaCl

-

-

+

+

-

SKMG+S = Kenney Extender (addition of sucrose); SKMG = Skim Milk Glucose; PYR2 = 0.2 g
pyruvate; PYR4 = 0.4 g pyruvate; PYR8 = 0.8 g pyruvate
*Antibiotics = Amikacin sulfate 1 g/dl and potassium penicillin 1 × 106 units/dl (KPenn)
**Added sufficient amount of salt to PYR2 and PYR4 in order to achieve osmality equal to all
other extenders
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RESULTS

Experiment 1
Mean values ± standard error were recorded for Oxyrase® treated aliquots compared to
untreated aliquots assessed by CASA after 2 hours, 24 hours, and 48 hours of storage post
collection. Results for all treatments for TM and PM are listed in Table 3, while the effects on
VAP, VSL, VCL, and ELONG are displayed in Table 4. Pairwise comparisons were made via a
Tukey test and results from each were recorded in Tables 5 – 7. Comparisons of stallions 1, 2, 3,
and 4 were analyzed for all sperm parameters at 2 hours, 24 hours, and 48 hours and recorded on
Tables 5, 6, and 7, respectively.
When all treatments were compared, a difference (P<0.05) was found in parameters VAP
and VCL with Oxyrase® supplemented treatments at 2 hours. No difference (P>0.05) was found
at 24 and 48 hours. However, contrary to results reported by Darr et al [2], throughout the
experiment Oxyrase® treatments tended to displayed lower motility and velocity percentages
when compared to treatments without Oxyrase®. In addition, numerical differences were found
among centrifuged and not centrifuged treatments, indicating centrifugation optimized
spermatozoa survivability, which is in agreement with previous research [38,54].
In comparison, stallions displayed several significant effects (P<0.05) on sperm motility
parameters. Total motility analyzed at 2 hours, 24 hours, and 48 hours, stallion 2 had a lower
motility (P<0.05) than that of stallions 1 and 3, while being numerically lower from stallion 4.
Progressive motility within stallion 2 also showed numerically lower results at all times when
compared to stallion 1, 3, and 4. However, a lower PM (P<0.05) was recorded at 48 h compared
to stallion 1.
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Table 3. Effects of Oxyrase® supplementation of extenders on motility of stallion spermatozoa centrifuged and non-centrifuged and
stored at 5 ℃ (experiment 1).
Treatments
Centrifuged

Not Centrifuged

Oxyrase® (+)

Oxyrase® (-)

Oxyrase® (+)

Oxyrase® (-)

2h

45.9±5.0a

54.2±4.6a

45.9±6.1a

48.8±4.7a

24h

44.4±6.7a

50.8±5.2a

37.7±6.4a

45.3±4.8a

48h

44.4±6.3a

50.5±4.5a

40.8±6.8a

44.6±5.3a

2h

30.1±3.7a

30.5±4.1a

25.9±3.8a

25.5±3.6a

24h

27.3±4.3a

26.8±3.1a

21.1±3.4a

21.6±3.3a

48h

28.2±3.8a

22.3±2.6a

18.3±3.7a

19.0±3.7a

TM

PM
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a, b

Row means (± Standard Error) with different superscripts are significantly different (P<0.05, Tukey’s pairwise comparisons). Row
and column means (± Standard Error) demonstrate percent Total Motility (TM) and Progressive Motility (PM) of each treatment
analyzed via Computer Assisted Sperm Analysis (CASA) at 2 hours, 24 hours, and 48 hours.

Table 4. Effects of Oxyrase® supplementation of extenders on velocity and elongation of stallion spermatozoa centrifuged and
non-centrifuged and stored at 5 ℃ (experiment 1).
Treatments
Centrifuged
Oxyrase® (+)

Not Centrifuged
Oxyrase® (-)

Oxyrase® (+)

Oxyrase® (-)
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VAP
2h
96.2±6.2b
113.5±5.2a
99.4±5.0ab
112.1±4.2a
24h
104.3±4.4a
113.0±5.2a
103.0±4.6a
114.9±4.6a
48h
100.2±3.5a
103.4±4.0a
107.9±5.2a
114.4±5.6a
VSL
2h
76.3±4.7a
85.6±4.1a
78.0±3.8a
85.7±4.2a
24h
80.8±3.1a
84.9±4.3a
79.7±3.0a
83.6±3.6a
48h
78.5±2.0a
73.6±2.0a
80.7±3.7a
80.8±4.7a
VCL
2h
182.3±11.8b
208.7±12.7a
177.1±9.0b
194.5±9.5ab
24h
203.5±7.8a
210.5±9.3a
190.5±9.7a
210.4±12.1a
48h
185.7±16.7a
203.9±7.7a
210.5±10.4a
218.6±12.5a
ELONG
2h
64.3±1.2a
65.4±1.4a
65.8±1.2a
64.3±1.0a
24h
64.8±1.0a
64.9±1.2a
66.1±1.2a
64.2±1.3a
48h
64.3±1.0a
64.9±1.0a
63.7±1.4a
64.5±1.3a
a, b
Row means (± Standard Error) with different superscripts are significantly different (P<0.05, Tukey’s pairwise comparisons). Row
and column means (± Standard Error) demonstrate percent average path velocity (VAP), straight-line velocity (VSL), curvilinear
velocity (VCL), and elongation (ELONG) of each treatment analyzed via Computer Assisted Sperm Analysis (CASA) at 2 hours, 24
hours, and 48 hours.

Table 5. Tukey’s comparisons of stallion effect on sperm motility, velocity, and elongation at 2
hours post collection (experiment 1).
Stallion
1
2
3
4
a
b
a
TM
59.6±3.0
33.5±3.0
51.4±6.5
50.3±4.2ab
PM

32.1±2.4a

20.0±1.5a

31.3±5.8a

28.6±3.2a

VAP

98.3±3.5b

94.5±2.6b

102.8±6.6b

125.6±3.5a

VSL

74.2±1.5b

75.1±1.3b

80.4±5.1b

95.9±4.5a

VCL

168.2±4.1b

167.2±3.7b

187.7±11.5b

239.5±7.0a

ELONG

67.6±1.0a

65.9±1.0a

65.8±1.0a

60.1±1.0b

a, b

Row means (± Standard Error) with different superscripts are significantly different (P<0.05).
Sperm parameters total motility (TM), progressive motility (PM), average path velocity (VAP),
straight-line velocity (VSL), curvilinear velocity (VCL), and elongation (ELONG) were
measured via Computer Assisted Sperm Analysis System (CASA).

Table 6. Tukey’s comparisons of stallion effect on sperm motility, velocity, and elongation after
24 hours of storage at 5 ℃ (experiment 1).
Stallion
1
2
3
4
a
c
ab
TM
58.4±3.6
28.6±3.8
52.1±6.9
39.0±4.5bc
PM

27.7±2.2a

17.8±2.0a

26.7±5.0a

24.7±3.7a

VAP

105.0±3.1b

96.3±2.6b

110.0±4.6ab

124.0±5.0a

VSL

77.4±1.2b

75.8±1.3b

82.3±3.3ab

93.5±4.5a

VCL

182.4±2.9b

176.7±5.2b

220.1±8.5a

235.8±8.9a

ELONG

67.4±0.3a

66.9±0.5a

65.7±1.0a

60.0±1.1b

a, b, c

Row means (± Standard Error) with different superscripts are significantly different
(P<0.05). Sperm parameters total motility (TM), progressive motility (PM), average path
velocity (VAP), straight-line velocity (VSL), curvilinear velocity (VCL), and elongation
(ELONG) were measured via Computer Assisted Sperm Analysis System (CASA).
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Table 7. Tukey’s comparisons of stallion effect on sperm motility, velocity, and elongation after
48 hours of storage at 5 ℃ (experiment 1).
Stallion
1
2
3
4
a
b
a
TM
60.4±2.5
27.4±4.7
48.8±5.9
43.7±5.0ab
PM

25.7±2.3a

13.4±2.6b

23.7±4.6ab

25.1±3.5ab

VAP

106.2±2.9a

99.2±2.9a

107.5±3.3a

113.0±7.8a

VSL

76.5±1.0a

74.3±1.1a

77.1±1.1a

85.7±6.0a

VCL

197.5±4.2a

190.0±6.2a

214.3±18.2a

216.9±15.0a

ELONG

66.1±1.0a

65.1±1.0a

65.2±1.0a

61.1±1.3b

a, b

Row means (± Standard Error) with different superscripts are significantly different (P<0.05).
Sperm parameters total motility (TM), progressive motility (PM), average path velocity (VAP),
straight-line velocity (VSL), curvilinear velocity (VCL), and elongation (ELONG) were
measured via Computer Assisted Sperm Analysis System (CASA).
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Experiment 2
Mean values ± standard error were recorded for pyruvate treated aliquots compared to
untreated aliquots assessed by CASA at 2 hours, 24 hours, and 48 hours post collection. Results
for all treatments for TM and PM are listed in Table 8, while the effects on VAP, VSL, VCL,
and ELONG are displayed in Table 9. Pairwise comparisons were made via a Tukey test and
results from each were recorded in Tables 10 – 12. Comparisons of stallions 1, 2, and 3 were
analyzed for all sperm parameters at 2 hours, 24 hours, and 48 hours and recorded on Tables 10,
11, and 12, respectively.
Differences (P<0.05) were observed throughout experiment 2 at 2 hours, 24 hours, and 48
hours. The SKMG+S extender, while not always significant, numerically was generally higher
than all other extenders within the experiment. Along with the SKMG+S extender, SKMG, when
compared to all pyruvate treatments, numerically always resulted in higher spermatozoa
parameter measurements. Within the pyruvate treatments, few statistical differences were found
and showed little variation between substituted amounts of pyruvate, especially at 24 hours and
48 hours. Results gathered in this experiment displayed the commercially available extenders
were superior to the SKMG extender with substituted pyruvate.
As in experiment 1, a stallion effect was present. Stallion 1 spermatozoa showed higher
(P<0.05) TM at 24 hours and PM at 24 and 48 hours than stallion 3. Numerically, stallion 1
spermatozoa displayed a higher TM and PM at 2 hours. Both stallion 1 and 3 were more motile
(P<0.05) in TM and PM than stallion 2 at all times recorded. In addition, stallion 3, at 2 hours,
exhibited a lower (P<0.05) VCL when compared to stallion 1.
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Table 8. Effect of pyruvate substitution for glucose in skim milk extenders on motility of stallion spermatozoa stored at 5 ℃
(experiment 2).
Treatments
SKMG+S

SKMG

PYR2

PYR4

PYR8

2h

87.6±4.2a

86.7±4.6a

85.8±4.4a

65.6±9.5b

77.0±5.7ab

24h

83.33±4.1a

82.4±4.8a

63.2±9.0ab

58.3±8.7b

58.0±9.1b

48h

78.4±6.0a

73.6±7.3a

52.3±12.6ab

55.2±9.2ab

43.9±12.4b

2h

58.9±4.3a

61.2±4.5a

52.3±5.1ab

38.7±7.9b

48.6±6.1ab

24h

54.8±4.8a

47.4±5.7a

25.4±5.2b

27.4±6.1b

23.7±5.8b

TM

PM
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48h
45.8±6.1a
37.4±6.2ab
19.6±5.5c
21.4±4.7c
16.4±6.4c
a, b
Row means (± Standard Error) with different superscripts are significantly different (P<0.05, Tukey’s pairwise comparisons).
Row and column means (± Standard Error) demonstrate percent Total Motility (TM) and Progressive Motility (PM) of each
treatment analyzed via Computer Assisted Sperm Analysis (CASA) at 2 hours, 24 hours, and 48 hours. SKMG+S = Kenney
Extender (addition of sucrose); SKMG = Skim Milk Glucose Extender; PYR2, PYR4, and PYR8 = 0.2 g, 0.4 g, and 0.8 g of
pyruvate, respectively.

Table 9. Effect of pyruvate substitution for glucose in skim milk extenders on velocity and elongation of stallion spermatozoa
stored at 5 ℃ (experiment 2).
Treatments
SKMG+S

SKMG

PYR2

PYR4

PYR8
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VAP
2h
140.4±4.4a
132.5±5.8ab
117.2±4.2bc
71.4±7.3d
96.3±4.8c
24h
130.3±7.0ab
133.1±7.0a
108.5±5.7bc
75.9±4.9d
94.3±5.6cd
48h
142.0±6.1a
141.2±4.1a
98.5±19.1b
78.0±7.3b
89.5±8.6b
VSL
2h
106.1±3.1a
107.7±4.4a
94.3±5.3ab
63.0±6.2c
77.1±4.3bc
24h
92.5±3.9a
94.1±5.8a
73.5±4.8b
60.2±3.8b
65.4±3.5b
a
a
b
b
48h
96.3±4.3
96.6±3.5
66.3±13.1
60.0±4.7
65.9±4.6b
VCL
2h
244.2±9.0a
209.7±9.9ab
194.8±7.5bc
119.7±11.3d
171.4±9.6c
24h
236.5±15.1a
228.5±12.5ab
213.6±10.5ab
130.4±9.1c
185.3±9.5b
48h
258.4±8.9a
247.3±7.0ab
183.1±35.3bc
139.7±11.8c
164.0±19.3c
ELONG
2h
61.0±1.0b
61.3±1.0b
61.9±1.0b
65.9±1.0a
61.9±1.0b
24h
60.8±1.0ab
61.6±1.0ab
61.1±1.0ab
64.9±1.0a
60.4±1.3b
48h
61.3±1.2a
61.6±1.0a
46.6±8.3b
64.3±1.0a
55.0±3.4ab
a, b
Row means (± Standard Error) with different superscripts are significantly different (P<0.05, Tukey’s pairwise comparisons).
Row and column means (± Standard Error) demonstrate percent Total Motility (TM) and Progressive Motility (PM) of each
treatment analyzed via Computer Assisted Sperm Analysis (CASA) at 2 hours, 24 hours, and 48 hours. SKMG+S = Kenney
Extender (addition of sucrose); SKMG = Skim Milk Glucose Extender; PYR2, PYR4, and PYR8 = 0.2 g, 0.4 g, and 0.8 g of
pyruvate, respectively.

Table 10. Tukey’s comparisons of stallion effect on sperm motility, velocity, and elongation at 2
hours post collection (experiment 2).
Stallion
1
2
3
a
b
TM
92.2±1.7
63.9±5.8
85.4±3.1a
PM

62.4±2.6a

39.6±5.0b

53.8±4.5a

VAP

118.7±7.9a

106.9±8.2a

109.1±7.0a

VSL

93.8±6.0a

85.1±5.5a

90.0±5.8a

VCL

204.7±12.1a

182.2±515.4ab

177.0±10.6b

ELONG

61.2±0.7b

63.3±0.8a

62.7±0.7ab

a, b

Row means (± Standard Error) with different superscripts are significantly different (P<0.05).
Sperm parameters total motility (TM), progressive motility (PM), average path velocity (VAP),
straight-line velocity (VSL), curvilinear velocity (VCL), and elongation (ELONG) were
measured via Computer Assisted Sperm Analysis System (CASA).

Table 11. Tukey’s comparisons of stallion effect on sperm motility, velocity, and elongation after
24 hours of storage at 5 ℃ (experiment 2).
Stallion
1
2
3
a
c
TM
86.8±2.7
48.5±5.0
71.9±5.4b
PM

48.6±4.7a

23.1±4.6c

35.5±4.7b

VAP

114.4±6.8a

108.6±9.2a

102.3±5.3a

VSL

83.7±5.5a

74.2±5.2a

73.5±3.6a

VCL

202.9±11.3a

204.7±17.1a

188.8±10.6a

ELONG

62.1±0.9a

61.6±1.0a

61.5±0.8a

a, b, c

Row means (± Standard Error) with different superscripts are significantly different
(P<0.05). Sperm parameters total motility (TM), progressive motility (PM), average path
velocity (VAP), straight-line velocity (VSL), curvilinear velocity (VCL), and elongation
(ELONG) were measured via Computer Assisted Sperm Analysis System (CASA).
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Table 12. Tukey’s comparisons of stallion effect on sperm motility, velocity, and elongation after
48 hours of storage at 5 ℃ (experiment 2).
Stallion
1
2
3
a
b
TM
81.3±6.2
32.5±6.9
68.3±5.1a
PM

42.0±5.2a

14.9±4.5c

27.5±3.5b

VAP

114.3±8.6a

96.3±13.3a

119.0±8.3a

VSL

80.4±5.8a

68.3±8.5a

82.4±5.0a

VCL

207.4±15.3a

171.1±23.9a

217.0±15.0a

ELONG

60.8±0.8a

50.9±5.8a

59.8±1.3a

a, b

Row means (± Standard Error) with different superscripts are significantly different (P<0.05).
Sperm parameters total motility (TM), progressive motility (PM), average path velocity (VAP),
straight-line velocity (VSL), curvilinear velocity (VCL), and elongation (ELONG) were
measured via Computer Assisted Sperm Analysis System (CASA).
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DISCUSSION

Experiment 1
Previous studies have established contradicting effects from addition of Oxyrase® to
diluents used for the preservation of stallion semen. Varying results are possibly due to the
procedures used and/or differences in the stallions used in the studies. In a study that observed a
positive effect from Oxyrase®, stallions with spermatozoa that had initial progressive motility
lower than 50% were used. In contrast a second study found no advantage when Oxyrase® was
added to extenders used to freeze semen from stallions that displayed an original motility >70%.
The results of the latter study are similar to those from the current study, in which stallion
spermatozoa were challenged by centrifugation and storage at 5oC for 48 hours.
Variability between the semen of different stallions is a well-known issue and contributes
as a major factor in results from treatments [55]. Dairy bulls, for example, have been continually
selected based on spermatozoa ability to withstand the stress of a standard cryopreservation
protocol. Subsequently, this has led to a positive response in the amount of bulls that can
withstand a specific protocol [55]. Stallions, however, are not as uniform to a specific protocol as
dairy bulls are. Selection criteria is much different for stallions and results in a wide variation in
spermatozoa response to cooling or freezing protocols. Examining Tables 5, 6, and 7, stallion 2,
which was used in both experiments, was lower (P<0.05) in TM than stallion 1 and 3, and
numerically lower than stallion 4 at all experiment times recorded. The response from stallion 2
was different (P<0.05) than that of 1, 3, and 4, showing one extender may work better for one
stallion than the other. A stallion effect was present (P<0.01) at all times for TM and ELG.
Velocity measurements were different (P<0.05) at 2 and 24 h, but not at 48 h, while differences
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(P<0.05) in PM were only demonstrated at 48 h. Evidence of a stallion effect has demonstrated
variability within the experiment and could be improved with a larger sample size to better
represent results from each extender.
Tukey’s comparisons within experiment 1 displayed a numerical difference between
centrifuged treatments and not centrifuged treatments. Treatments that were centrifuged tended
to have higher TM and PM when compared to treatments without centrifugation. This is in
agreement with literature stating ejaculates that are centrifuged tend to have higher motility than
those not centrifuged [1,38,54,56].

Experiment 2
In experiment 2, a stallion effect was present. Stallion 2 showed lower (P<0.01) TM and
PM at all times measured when compared to stallion 1 and 3. Results were similar between both
experiments, in which stallion 2 demonstrated lower motility than the other stallions within the
experiments. As mentioned above, this lack of sample size increases variation within stallions
and could affect the statistical differences within the experiment. However, it is important to test
experimental procedures across stallions that are known to have lower post storage motility as
these are common in the industry.
The diluents with formulas which are commonly used, SKMG+S and SKMG
demonstrated numerically higher TM and PM than extenders in which pyruvate was substituted
for glucose as an energy source. At 2 hours, a significantly (P<0.05) lower TM and PM was
revealed in the extender PYR4. Analysis at 24 hours resulted in all pyruvate extenders but PYR2
to be significantly (P<0.05) lower than that of SKMG+S and SKMG. Finally, analysis at 48

36

hours demonstrated similar results suggesting replacement of glucose with pyruvate was not
beneficial.
Contrary to results from Bruemmer et al. [51], Potter et al. [9], Cavinder et al. [6], and
Darr et al. [2], the skim milk extenders with pyruvate did not tend to show any benefit from its
inclusion compared to commonly used extender formulas. Furthermore, increasing the
concentration of pyruvate in the diluent has also been suggested to result in an increase of
motility, due to the more direct metabolism of pyruvate compared to glucose [2]. In agreement
with results from Webb and Arns [1], inclusion and increasing concentrations of pyruvate did not
improve motility of the supplemented aliquots. Conversely, the highest amount of pyruvate
substituted was in PYR8 and at 48 hours, numerically, the extender had the lowest percent TM
and PM. However it should be mentioned, that an increase in sample size may potentially lead to
statistically different results across treatments.

Limitations
Spermatozoa are highly sensitive to the suspended environment and protocols implicated
in the handling of each ejaculate. The reduction of error, such as operator error and
environmental effects, can be attained by organized procedures and precise execution of such
procedures. In agreement with previous research, stallion effects are a continuous difficult factor
to adjust due to the nature of variability within different stallions. Diminishing variability could
be achieved by executing precise procedures, increasing the sample size, and increasing the
number of ejaculates collected, insuring no ejaculate effect could hinder results within different
stallions. Increasing the stallion sample size could possibly result in an increase in the
significance level within this current study.
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CONCLUSIONS

Previous research has indicated that Oxyrase® may be beneficial when included in a
cryopreservation protocol. However in this study, no significant differences were shown when
EC-Oxyrase® was added to INRA 96 with or without centrifugation to remove the majority of
the seminal plasma. Based on these results it was determined that supplementation of ECOxyrase® may not warrant the additional cost to include the antioxidant in diluents for cold
storage of stallion spermatozoa. However, in agreement with previous research, results revealed
a positive effect of seminal plasma removal by centrifugation. Centrifuged ejaculates,
numerically, had a higher percent motility than ejaculates not centrifuged; thus, increasing data
for beneficial effects of centrifugation to stallion semen before suspension in extender for some
stallions.
Inclusion of pyruvate has been suggested by previous research to benefit stallion
spermatozoa suspended in extenders for transportation with the intent of artificial insemination.
However, potentially due to lack of sample size, handling/procedures and stallion effect, results
from this study did not conclude substitution of pyruvate for glucose, in formulas similar to
commercially available ones, was beneficial in increasing motility of spermatozoa. Due to the
differences in stallions, an increase in the number of stallions collected would be beneficial.
Certain stallions may respond better to certain extenders than others. Increasing the sample size
will better represent the response from the general stallion population.
In the current equine market, sire selection is based on pedigree, performance record and
conformation. Fertility should be considered along with athletic and performance characteristics
of young stallions. Reproductive traits in stallions are heritable [57]. In addition, per cycle
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conception within stallions, specifically thoroughbreds, is variable, ranging anywhere from 35%
to 90% [58]. Variability has also been demonstrated in this study and can hinder results from an
experiment with a smaller sample size.
More studies are necessary to determine the inclusion effects of the addition of energy
substrates and antioxidants similar to and including pyruvate and Oxyrase®, respectively. The
development of precise techniques and extenders will aid in alleviating error within spermatozoa
preservation; this can prolong the capability of stallion spermatozoa to remain motile after cold
storage. Thus, increasing the number of stallions available for breeding and access to superior
genetics, while also increasing effectiveness of each ejaculate allowing for more inseminations
and less shipments required to attain pregnancy.

39

REFERENCES

[1] Webb GW, Arns MJ. Effect of pyruvate and lactate on motility of cold stored stallion
spermatozoa challenged by hydrogen peroxide. J Equine Vet Sci 2006;26:406–11.
[2] Darr CR, Varner DD, Teague S, Cortopassi GA, Datta S, Meyers SA. Lactate and pyruvate
are major sources of energy for stallion sperm with dose effects on mitochondrial function,
motility, and ROS production. Biol Reprod 2016;95:34–34.
[3] Darr CR, Cortopassi GA, Datta S, Varner DD, Meyers SA. Mitochondrial oxygen
consumption is a unique indicator of stallion spermatozoal health and varies with
cryopreservation media. Theriogenology 2016;86:1382–92.
[4] Aurich C. Recent advances in cooled-semen technology. Anim Reprod Sci 2008;107:268–75.
[5] Bilodeau JF, Blanchette S, Cormier N, Sirard MA. Reactive oxygen species-mediated loss of
bovine sperm motility in egg yolk Tris extender: Protection by pyruvate, metal chelators and
bovine liver or oviductal fluid catalase. Theriogenology 2002;57:1105–22.
[6] Cavinder CA, Harrison K, Webb GW. Antioxidant effects of pyru- vate as a component of
extenders for stallion semen. Proc Equine Nutr Physiol Soc Symp; 2003:262–263.
[7] London KT, Christensen BW, Scott CJ, Klooster K, Kass PH, Dujovne GA, et al. The effects
of an oxygen scavenger and coconut water on equine sperm cryopreservation. J Equine Vet Sci
2017;58:51–7.
[8] Ball B, Medina V, Gravance C, Baumber J. Effect of antioxidants on preservation of motility,
viability and acrosomal integrity of equine spermatozoa during storage at 5°C. Theriogenology
2001;56:577–89.
[9] Potter DS, Webb GW, Onyango B, Northcutt T. 134 l-Carnitine and pyruvate inclusion in
diluents for cold-stored stallion spermatozoa. J Equine Vet Sci 2015;35:440.
[10] Upreti GC, Jensen K, Munday R, Duganzich DM, Vishwanath R, Smith JF. Studies on
aromatic amino acid oxidase activity in ram spermatozoa: Role of pyruvate as an antioxidant.
Anim Reprod Sci 1998;51:275–87.
[11] Waheed MM, El-Bahr SM, Al-haider AK. Influence of seminal plasma antioxidants and
osteopontin on fertility of the Arabian horse. J Equine Vet Sci 2013;33:705–9.
[12] Gibb Z, Lambourne SR, Aitken RJ. The paradoxical relationship between stallion fertility
and oxidative stress. Biol Reprod 2014;91:1–10.

40

[13] Mazur P, Katkov II, Katkova N, Critser JK. The enhancement of the ability of mouse sperm
to survive freezing and thawing by the use of high concentrations of glycerol and the presence of
an Escherichia coli membrane preparation (Oxyrase) to lower the oxygen con- centration.
Cryobiology 2000;40:187–209.
[14] Dong QX, Tollner TL, Rodenburg SE, Hill DL, VandeVoort CA. Anti- oxidants, Oxyrase,
and mitochondrial uncoupler 2,4-dinitrophenol improved post thaw survival of rhesus monkey
sperm from ejaculates with low cryosurvival. Fertil Steril 2010;94:2359–61.
[15] Borg CL, Wolski KM, Gibbs GM, O’Bryan MK. Phenotyping male infertility in the mouse:
how to get the most out of a ‘non-performer’. Human Reproduction Update 2010;16:205-224.
[16] Langlais J, Roberts KD. A Molecular Membrane Model of Sperm Capacitation and the
Acrosome Reaction of Mammalian Spermatozoa. Gamete Research 1985;224:183–224.
[17] Voet D, Voet JG, Pratt CW. Fundamentals of Biochemistry. 4th ed. New York: Wiley; 1998.
[18] Parks JE, Lynch DV. Lipid composition and thermotropic phase behavior of boar, bull,
stallion, and rooster sperm membranes preparation of sperm lipid extraction and fractionation.
Cryobiology 1992;266:255–66.
[19] Moce´ E, Blanch E, Toma C. Use of cholesterol in sperm cryopreservation : present moment
and perspectives to future treatment of sperm with cyclodextrins pre-loaded with cholesterol
(CLC) 2010;45:57–66.
[20] Oldenhof H, Heutelbeck A, Blässe AK, Bollwein H, Martinsson G, Wolkers WF, et al.
Tolerance of spermatozoa to hypotonic stress: role of membrane fluidity and correlation with
cryosurvival. Reproduction, Fertility and Development 2015;27:285.
[21] Flesch FM, Gadella BM. Dynamics of the mammalian sperm plasma membrane in the
process of fertilization. Biochimica et Biophysica Acta. 2000;1469:3:197-235.
[22] Buffone MG, Foster JA, Gerton GL. The role of the acrosomal matrix in fertilization. Int J
Dev Biol 2008;52:511–22.
[23] Varner DD, Gibb Z, Aitken RJ. Stallion fertility: A focus on the spermatozoon 2015;47:16–
24.
[24] Love CC, Varner DD, Thompson J.A. Intra- and inter-stallion variation in sperm
morphology and their relationship with fertility. J. Reprod. Fertil. Suppl 2000. 56, 93-100.
[25] Storey BT. Mammalian sperm metabolism: Oxygen and sugar, friend and foe. Int J Dev
Biol 2008.
[26] Bucci D, Rodriguez-Gil JE, Vallorani C, Spinaci M, Galeati G, Tamanini C. Gluts and
mammalian sperm metabolism. J Androl 2011.

41

[27] Piomboni P, Focarelli R, Stendardi A, Ferramosca A, Zara V. The role of mitochondria in
energy production for human sperm motility. International Journal of Andrology 2011;35:109–
24.
[28] Davila MP, Muñoz PM, Tapia JA, Ferrusola CO, Da Silva C CB, Peña FJ. Inhibition of
mitochondrial complex I leads to decreased motility and membrane integrity related to increased
hydrogen peroxide and reduced ATP production, while the inhibition of glycolysis has less
impact on sperm motility. PLoS One 2015.
[29] Aitken RJ, Baker MA. Oxidative stress and male reproductive biology. Reprod Fertil Dev
2004;16:581–8.
[30] Aitken JR, Gibb Z, Baker MA, Drevet J, Gharagozloo P. Causes and consequences of
oxidative stress in spermatozoa. Reprod Fertil Dev 2016;28:1–10.
[31] Nordberg J, Arnér ES. Reactive oxygen species, antioxidants, and the mammalian
thioredoxin system. Free Radic Biol Med 2001;31: 1287–312.0.
[32] Jones R, Mann T, Sherins RJ. Adverse effects of peroxidized lipid on human spermatozoa.
Proc R Soc London - Biol Sci 1978;201:413–7.
[33] Moazamian R, Polhemus A, Connaughton H, Fraser B, Whiting S, Gharagozloo P, et al.
Oxidative stress and human spermatozoa: Diagnostic and functional significance of aldehydes
generated as a result of lipid peroxidation. Mol Hum Reprod 2015;21:502–15.
[34] Aitken RJ, Whiting S, De Iuliis GN, McClymont S, Mitchell LA, Baker MA. Electrophilic
aldehydes generated by sperm metabolism activate mitochondrial reactive oxygen species
generation and apoptosis by targeting succinate dehydrogenase. J Biol Chem 2012;287:33048–
60.
[35] Aitken RJ, De Iuliis GN, Finnie JM, Hedges A, McLachlan RI. Analysis of the relationships
between oxidative stress, DNA damage and sperm vitality in a patient population: Development
of diagnostic criteria. Hum Reprod 2010;25:2415–26.
[36] Aitken RJ, Clarkson JS. Cellular basis of defective sperm function and its association with
the genesis of reactive oxygen species by human spermatozoa. J Reprod Fert 1987;81:459–69.
[37] Baumber J, Ball BA, Gravance CG, Medina V, Davies-Morel MC. The effect of reactive
oxygen species on equine sperm motility, viability, acrosomal integrity, mitochondrial
membrane potential, and membrane lipid peroxidation. J Androl 2000;21:895–902.
[38] Dawson GR, Webb GW, Pruitt JA, Loughin TM, Arns MJ. Effect of different processing
techniques on motility and acrosomal integrity of cold-stored stallion spermatozoa. J Equine Vet
Sci 2000;20:191–4.

42

[39] Ramires Neto C, Monteiro GA, Soares RF, Pedrazzi C, Dell’aqua JA, Papa FO, et al. New
seminal plasma removal method for freezing stallion semen. Theriogenology 2013;79:1120–3.
[40] Kawai GKV, Gurgel JRC, Losano JD de A, Dalmazzo A, Rocha CC, Tsunoda RH, et al.
Susceptibility of stallion spermatozoa to different oxidative challenges: role of seminal plasma. J
Equine Vet Sci 2017;55:76–83.
[41] Kankofer M, Kolm G, Aurich J, Aurich C. Activity of glutathione peroxidase, superoxide
dismutase and catalase and lipid peroxidation intensity in stallion semen during storage at 5°C.
Theriogenology 2005;63:1354–65.
[42] Alvarez J, Storey B. Spontaneous lipid peroxidation in rabbit and mouse epididymal
spermatozoa: dependence of rate on temperature and oxygen concentration the considerably.
Biol Reprod 1985:342–51.
[43] Neild DM, Gadella BM, Chaves MG, Miragaya MH, Colenbrander B, Agüero A.
Membrane changes during different stages of a freeze-thaw protocol for equine semen
cryopreservation. Theriogenology 2003;59:1693–705.
[44] Adler HI. The use of microbial membranes to achieve anaerobiosis. Crit Rev Biotechnol
1990;10:119–27.
[45] Metcalf ES. Pregnancy rates with cooled equine semen received in private practice. AAEP
Proceedings 1998;44:16–8.
[46] Mccommis KS, Finck BN. Mitochondrial pyruvate transport: a historical perspective and
future research directions. Biochem J 2015;466:443–54.
[47] Gray LR, Tompkins SC, Taylor EB. Regulation of pyruvate metabolism and human disease.
Cell Mol Life Sci 2014;71:2577–604.
[48] Mendes-Mourão J, Halestrap A, Crisp DM, Pogson CI. The involvement of mitochondrial
pyruvate transport in the pathways of gluconeogenesis from serine and alanine in isolated rat and
mouse liver cells. FEBS Lett 1975;53:29–32.
[49] Herzig S, Raemy E, Montessuit S, Veuthey JL, Zamboni N, Westermann B, et al.
Identification and functional expression of the mitochondrial pyruvate carrier. Science (80- )
2012;336:93–6.
[50] Owen OE, Kalhan SC, Hanson RW. The key role of anaplerosis and cataplerosis for citric
acid cycle function. J Biol Chem 2002;277:30409–12.
[51] Bruemmer JE, Coy RC, Squires EL, Graham JK. Effect of pyruvate on the function of
stallion spermatozoa stored for up to 48 hours. J Anim Sci 2002;80:12–8.

43

[52] Stendardi A, Focarelli R, Piomboni P, Palumberi D, Serafini F, Ferramosca A, et al.
Evaluation of mitochondrial respiratory efficiency during in vitro capacitation of human
spermatozoa. Int J Androl 2011;34:247–55.
[53] Ferramosca A, Pinto Provenzano S, Montagna, DD, Coppola L, Zara V. Oxidative Stress
Negatively Affects Human Sperm Mitochondrial Respiration. Urology 2013;82:78-83.
[54] Brinsko SP, Crockett EC, Squires EL. Effect of centrifugation and partial removal of
seminal plasma on equine spermatozoal motility after cooling and storage. Theriogenology
2000;54:129–136.
[55] Loomis PR, Graham JK. Commercial semen freezing: individual male variation in
cryosurvival and the response of stallion sperm to customized freezing protocols. Anim Reprod
Sci 2008;105:119–28.
[56] Webb GW, Dean MM. Effect of Centrifugation Technique on Post-storage Characteristics
of Stallion Spermatozoa. J Equine Vet Sci 2009;29:675–80.
[57] Parlevliet J, Kemp B, Colenbrander B. Reproductive characteristics and semen Warmblood
stallions quality in maiden Dutch Warmblood stallions. J Reprod Fertil 1994;101:183–7.
[58] Morris LHA, Allen WR. Reproductive efficiency of intensively managed Thoroughbred
mares in Newmarket. Equine Veterinary Journal 2010;34:51–60.

44

